Intellia Therapeutics NTLA Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Intellia Therapeutics's total revenue?
- Intellia Therapeutics (NTLA) reported total revenue of $15.05M in Q1 2026.
- How has Intellia Therapeutics's total revenue changed year-over-year?
- Intellia Therapeutics's total revenue decreased by 9.5% year-over-year, from $16.63M to $15.05M.
- What is the long-term trend for Intellia Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Intellia Therapeutics's total revenue has grown at a 19.6% compound annual growth rate (CAGR), from $33.05M to $67.67M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.